Boston Scientific (BSX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $49.37 --0%
Financial Fact:
Cost of products sold: 594M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of products sold: 594M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.08, $0.10 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.73 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
